🇺🇸

US SEC Filing Intelligence

· daily

Nasdaq 100 Stocks SEC Filings — July 13, 2026

The four filings from NASDAQ-100 constituents reveal a mixed picture: insider activity at Intuitive Surgical and Cisco shows routine tax-related stock movements rather than conviction signals, while Strategy Inc. continues its aggressive capital markets activity, selling $466.7M in equity via its ATM program but pausing bitcoin purchases for the week. Cisco's 13F filing discloses a concentrated portfolio heavily weighted toward broad-market ETFs and a notable $105.9M stake in CoreWeave, signaling a strategic bet on AI infrastructure. No period-over-period comparisons or forward-looking guidance were provided in any filing, limiting trend analysis. The key takeaway is that capital allocation patterns diverge sharply—Strategy Inc. is aggressively funding its bitcoin treasury via equity issuance, while Cisco and Intuitive Surgical show no buyback or dividend activity in these filings. The absence of insider buying or selling for conviction purposes suggests management teams are in a 'steady state' mode, with no urgent signals to act upon.

2 high priority 2 medium 4 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — July 13, 2026

The July 13, 2026, batch of 29 filings reveals a mixed landscape for activist and institutional activity, with a notable tilt toward passive position disclosures and a few high-conviction activist engagements. The most critical development is **Fresenius Medical Care's** planned exit from **Humacyte** via a 10b5-1 plan to sell up to 6.8% of the company, a strong bearish signal for the biotech. Conversely, **Xerox Holdings** saw activist **STARTEEPO Invest** increase its stake to 6.84% and signal a more active engagement on strategy, while **IRIDEX Corp** remains under the influence of a 29.92% holder with a 12% interest note. The data shows a clear pattern of passive institutional investors (Millennium, D.E. Shaw, Wasatch) making routine 13G filings, indicating a wait-and-see approach. A key period-over-period trend is the complete exit of **Jericho Capital** from **Upstart Holdings** and the reduction of **Impactive Capital** below 5% in **Asbury Automotive**, suggesting a loss of conviction in those names. Overall, the digest points to selective activist pressure in value/industrial plays and a cautious, passive posture from large asset managers, with the Humacyte sell-down being the most actionable bearish event.

7 high priority 22 medium 29 total filings
· daily

S&P 500 Financials Sector SEC Filings — July 13, 2026

The sole filing in this period, from Capital One Multi-Asset Execution Trust, is a routine 8-K announcing the issuance of two classes of asset-backed notes (Class A 2026-1 and 2026-2) on July 16, 2026. The filing contains no financial performance data, period-over-period comparisons, insider activity, or forward-looking guidance, resulting in a neutral sentiment and low materiality score of 3/10. This is a standard operational update for a structured finance vehicle, offering no actionable investment signals for the broader S&P 500 Financials sector. The absence of any substantive financial or strategic data from the only filing in scope limits the ability to identify sector-wide trends or generate alpha-generating insights. Investors should view this as a non-event for portfolio positioning, with no implications for the financial sector's earnings trajectory or risk profile.

1 medium 1 total filings
· daily

S&P 500 Energy Sector SEC Filings — July 13, 2026

The three filings in the S&P 500 Energy stream for July 13, 2026, present a mixed picture of insider sentiment and strategic capital deployment. A notable insider purchase by a 10% owner at Texas Pacific Land Corp, though small in size, signals long-term conviction in the company's value at current levels. Conversely, a large, pre-planned sale by the CFO of Phillips 66, following a stock option exercise, introduces a bearish signal for that specific name, though the use of a 10b5-1 plan tempers the alarm. The most significant strategic development comes from Williams Companies, which announced a joint venture financing for behind-the-meter Power Innovation projects, a clear pivot towards the growing data center and electrification demand theme. The lack of specific financial guidance in the Williams filing creates uncertainty, but the strategic direction is a positive catalyst for the sector. Overall, the day's filings highlight a divergence between capital returns to executives and strategic reinvestment in energy transition infrastructure.

2 high priority 1 medium 3 total filings
· daily

S&P 500 Industrials Sector SEC Filings — July 13, 2026

All five filings today are from Union Pacific Corp (UNP), a core S&P 500 Industrials railroad company, and exclusively report routine insider stock awards to senior executives. There are no period-over-period comparisons, forward-looking guidance, capital allocation changes, or transaction details in the enriched data, limiting the depth of trend analysis. The awards are small in value (ranging from ~$635 to ~$2.4K) and represent standard compensation grants, not open-market purchases or sales, indicating neutral management sentiment with no actionable conviction signals. The aggregate insider holdings post-transaction (e.g., CFO holds 114,667 shares) suggest significant alignment with shareholders, but the lack of any material financial or operational disclosures means the overall portfolio-level signal is muted. The key takeaway is a stable, routine insider activity pattern with no red flags or catalysts, reinforcing a steady-state view for Union Pacific in the near term.

5 high priority 5 total filings
· daily

US Material Events SEC 8-K Filings — July 13, 2026

The July 13, 2026, filings reveal a market sharply bifurcated between aggressive capital deployment and acute financial distress. Major capital markets events dominate, with **Public Storage** raising $900M in senior notes to fund a transformative acquisition and **Talos Energy** issuing $800M in high-yield notes for a Gulf of America acquisition, while **Realty Income** expanded its credit facilities to $5.5B. The biotech sector saw a landmark transaction as **Edgewise Therapeutics** sold its muscular dystrophy business for up to $2.65B, and **Agenus** secured $340M for a pivotal Phase 3 trial. Conversely, several companies are in dire straits: **MSP Recovery** received a $250K emergency advance amid ongoing financial distress, **Splash Beverage** settled $2.8M in debt for a mere $302K, and **Silo Pharma** is raising $11.7M via a dilutive private placement. A wave of insider activity is notable, with multiple CFO and CRO departures, including **CoStar Group** appointing a new CFO who delivered a 25% cost reduction, and **Shutterstock** seeing its CEO step down immediately. The overall sentiment is mixed, with large-scale strategic moves and liquidity events contrasting with numerous small-cap distress signals and leadership transitions.

50 high priority 50 total filings
· daily

Insider Trading Pulse — July 13, 2026

Today's insider trading digest reveals a clear bifurcation: aggressive insider buying by CEOs and directors at several small/mid-cap companies, contrasted with massive insider selling at large-cap growth names. The most significant buying signals come from Dreamland Ltd (CEO $2.45M purchase) and 51Talk Online Education Group (CEO $9.3M in 10b5-1 purchases), while the largest sales are at UNITED MICROELECTRONICS (CFO $294M sale) and SharkNinja (Director $401M sale). A notable cluster of option exercises and tax-withholding sales at Calumet, Esperion Therapeutics, and Octave Specialty Group suggests these are routine compensation events rather than conviction-based trades. The Esperion Therapeutics filings show a coordinated disposition of shares and options by the entire C-suite and board, likely tied to a corporate event. Period-over-period comparisons were not available in the enriched data for most filings, limiting trend analysis, but the sheer volume and direction of insider activity provide actionable signals.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — July 13, 2026

The two filings from Cisco Systems, Inc. for July 13, 2026, provide limited but actionable intelligence within the Dow 30 context. The 13F-HR reveals a concentrated investment portfolio heavily weighted toward broad-market ETFs and a notable new stake in CoreWeave Inc., signaling a strategic bet on AI infrastructure. The Form 4 insider transaction shows a routine tax-withholding sale by the EVP of Global Sales, which is not a bearish signal but does reduce insider holdings marginally. No period-over-period comparisons, forward-looking guidance, or capital allocation changes were present in either filing, limiting trend analysis. The key takeaway is Cisco's disclosed equity exposure to CoreWeave, which aligns with broader sector themes of AI-driven capital deployment. Overall, the digest is thin on quantitative trends but offers a specific catalyst in Cisco's AI investment positioning.

1 high priority 1 medium 2 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — July 13, 2026

The three filings paint a stark picture of distress among micro-cap companies listed on Nasdaq, with all three facing delisting or imminent suspension due to non-compliance with listing standards. Pluri Inc., Actelis Networks Inc., and BNB Plus Corp. all received negative delisting or non-compliance notices within a single week (July 7-10, 2026), indicating a concentrated wave of corporate distress. None of the companies provided forward-looking guidance, insider trading activity, or capital allocation data in their filings, suggesting a lack of strategic communication or financial flexibility. The common theme is a failure to meet minimum market value or bid price requirements, with all three companies either already trading on the OTCQB Venture Market or facing imminent transfer. The absence of any positive period-over-period trends or recovery plans underscores the severity of their situations, making these high-risk, low-recovery scenarios for equity holders.

3 high priority 3 total filings
· daily

Global High-Priority Regulatory Events — July 13, 2026

This digest covers 50 filings, predominantly focused on severe distress signals across US and Indian markets. The most critical theme is a wave of Nasdaq delistings, with 8 companies facing final removal in late July 2026, including Esperion Therapeutics, CERO Therapeutics, and REE Automotive, reflecting a broad failure to meet listing standards. M&A activity is bifurcated: high-value strategic deals like Edgewise Therapeutics' $1.55B asset sale contrast with numerous small-scale acquisitions and SPAC maneuvers. A significant cluster of Indian companies (MTNL, Ansal Properties, Simbhaoli Sugars, Reliance Home Finance) are in advanced stages of insolvency or default, highlighting systemic stress in Indian real estate and telecom. Insider activity is notably absent across all filings, a bearish signal suggesting management lacks conviction. Forward-looking data reveals a packed catalyst calendar with several tender offers and SPAC deadlines expiring in late July and August 2026.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — July 13, 2026

Today's digest is dominated by corporate actions and governance events, with a notable cluster of proxy fights and M&A-related votes. The most critical development is the impending delisting of Bowen Acquisition Corp (BOWN) from Nasdaq, a high-severity event that crystallizes the risks of SPAC investing. A significant proxy battle is underway at XAI Octagon Floating Rate & Alternative Income Trust (XFLT), where the board is seeking to replace the severely underperforming sub-adviser Octagon, who is fighting back. The merger of equals between Equitable Holdings and Corebridge Financial is driving a wave of proxy solicitations across multiple AB funds, creating a near-term catalyst calendar. On the financial health front, Patriot National Bancorp's removal of its 'troubled condition' designation marks a major turnaround, while Onar Holding Corp's deteriorating cash position and widening deficit present a stark contrast. Period-over-period trends from the limited operating data available show a mixed picture: Onar's revenue grew 39% YoY but gross profit collapsed 41%, while Royale Energy narrowed its net loss by 42% despite a 14% revenue decline. The 13F filings reveal a defensive posture among institutional managers, with heavy allocations to fixed-income, inflation-protected, and large-cap ETFs, signaling cautious market positioning.

11 high priority 39 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — July 13, 2026

The three filings from the S&P 500 Healthcare sector—Edwards Lifesciences, Intuitive Surgical, and Pfizer—reveal a sector dominated by routine insider transactions related to tax withholding and equity compensation, with no overtly bullish or bearish signals. The lack of significant period-over-period comparisons, forward-looking guidance, or capital allocation changes across these filings suggests a quiet period for these companies, with no material shifts in financial health or management outlook. The most notable insider activity is from Intuitive Surgical's CEO, who exercised and had shares withheld for taxes, a common practice that does not indicate a change in conviction. Overall, the sector appears stable with no immediate catalysts or red flags from these specific filings, though the absence of strong signals may imply a wait-and-see approach for investors.

3 high priority 3 total filings
· daily

US Earnings Financial Results SEC Filings — July 13, 2026

The 12 filings reveal a bifurcated landscape: pre-revenue and early-stage companies (Lexaria, SolarWindow, Lantics, Apex 11, Jubilant Flame) continue to burn cash with widening losses, while a few entities show operational turnarounds (Solitron Devices, Iron Horse Acquisition II) or revenue growth (Onar Holding). The most striking portfolio-level trend is the severe cash burn and asset depletion across micro-cap names—Crypto Co's assets collapsed 85%, Onar's cash dropped 88%, and multiple companies (Apex 11, Jubilant Flame, Lantics) have near-zero cash positions, signaling imminent financing needs or going-concern risks. On the positive side, Solitron Devices posted a remarkable 101% revenue surge and swung to a $990K profit from a $336K loss, while Iron Horse and XFLH Capital (SPACs) generated substantial trust account interest income. Insider trading activity was notably absent across all filings, which is a neutral signal but warrants monitoring. Capital allocation is minimal—no dividends or buybacks—with most companies relying on equity or debt financing. The forward-looking data is sparse, but the scheduled events (earnings calls for Solitron, BAB, and others) provide near-term catalysts. Overall, the digest highlights extreme risk in pre-revenue micro-caps and selective turnaround opportunities in niche industrials and SPACs.

12 high priority 12 total filings
· daily

US Executive Compensation Proxy SEC Filings — July 13, 2026

This batch of 11 proxy filings reveals a market dominated by transformative corporate actions, including two major mergers (AvalonBay/Equity Residential and Huntsman/Olin) and a high-premium biotech acquisition (Apogee Therapeutics at a 53% premium). A notable trend is the prevalence of corporate governance and structural changes, with Weatherford International redomesticating from Ireland to Delaware, Sphere 3D moving from Ontario to British Columbia, and Faraday Future undergoing a CEO shake-up while seeking shareholder approval for a dilutive convertible note conversion. Insider ownership patterns are mixed: while SharonAI Holdings shows concentrated insider control (45.94% voting power), Faraday Future's executives and directors collectively own less than 1% of shares, signaling a significant misalignment of interests. Period-over-period comparisons are limited in these filings, but the financial data available points to operational stress at Huntsman and Olin, both reporting net losses in 2025. The overall sentiment is neutral to mixed, with the most actionable intelligence centered on the merger arbitrage opportunities in the AvalonBay/Equity Residential and Apogee deals, and the governance risks at Faraday Future and Weatherford.

11 high priority 11 total filings
· daily

US IPO Pipeline SEC S-1 Filings — July 13, 2026

The IPO pipeline is active with four new S-1 filings, highlighting a mix of healthcare technology, industrial laser, and SPAC offerings. The filings reveal a cautious market sentiment, with two companies (Nuburu and N2OFF) showing significant ongoing losses and negative sentiment, while Avalon GloboCare and Material Resource Acquisition Corp. present neutral profiles. Period-over-period data is limited, but N2OFF's pro forma financials show a net loss of $6.841 million with no revenue from its recent acquisition, indicating operational challenges. Insider activity is sparse, but management changes at Avalon GloboCare and complex capital structures at Nuburu and N2OFF signal potential governance and dilution risks. The SPAC offering from Material Resource Acquisition Corp. provides a traditional blank-check structure with a $200 million target, reflecting continued interest in SPACs despite regulatory scrutiny. Overall, the pipeline is weighted towards riskier, early-stage companies, with only the SPAC offering a more conventional investment profile.

4 high priority 4 total filings
· daily

USA Institutional Investor Activity — July 13, 2026

The sole filing in this intelligence stream is a 13F-HR from Parkside Investments, LLC, covering holdings as of June 30, 2026. The filing reveals a portfolio heavily concentrated in fixed-income and preferred-income ETFs, notably ISHARES 1-5 YEAR INVESTMENT GRADE CORPORATE BOND ETF and FIRST TRUST PREFERRED SECURITIES & INCOME ETF, suggesting a defensive, income-oriented strategy. However, the enriched data lacks period-over-period comparisons, insider activity, forward-looking guidance, and capital allocation details, severely limiting trend analysis and actionable insights. Without changes versus prior filings, it is impossible to determine if positions were increased or decreased, making the filing's materiality moderate at best. The neutral sentiment and absence of bullish or bearish signals mean this filing offers no clear directional intelligence for institutional investor activity. As a result, this digest is constrained, and the filing is best treated as a data point for monitoring rather than a source of immediate investment signals.

1 medium 1 total filings
· daily

US SEC Trading Suspension Halt Orders — July 13, 2026

Three US-listed micro-cap companies received Nasdaq delisting or suspension notices on July 7-10, 2026, underscoring a severe liquidity and compliance crisis in the small-cap space. Pluri Inc. (PLUR) faces a market value deficiency with a cure period through January 4, 2027, while Actelis Networks (ASNS) has already been suspended and moved to OTCQB, and BNB Plus Corp. (BNBX) will be suspended July 14. All three filings carry negative sentiment and high materiality (9-10/10), with no insider buying, no forward guidance, and no capital allocation actions (dividends/buybacks) reported—indicating distressed balance sheets. The cluster of delistings within a single week suggests heightened regulatory scrutiny on minimum listing standards, particularly for companies with market caps below $35 million. Investors should monitor the OTCQB transition for potential price discovery dislocations and short-squeeze dynamics, while avoiding long exposure until compliance is restored.

3 high priority 3 total filings
· daily

US Executive Officer Management Changes SEC — July 13, 2026

This digest of 31 SEC filings reveals a significant wave of C-suite and board-level transitions, with a notable trend of internal promotions and orderly successions. Key themes include the departure of CEOs at Shutterstock and Brown-Forman triggering strategic reviews, and a CFO transition at CoStar Group where an internal candidate with a proven track record of cost reduction is promoted. A critical governance risk flag is raised by the resignation of a Fermi Inc. director over a disputed $350 million convertible bond issuance, signaling potential internal control issues. While most changes are non-contentious, the sheer volume of leadership shifts, including new CFOs at Workhorse, Klaviyo, and MBX Biosciences, suggests a period of strategic repositioning across multiple sectors. The data shows a clear preference for promoting internal talent or appointing executives with deep industry experience, which generally signals stability. However, the lack of disclosed financial metrics in many filings limits the ability to assess the immediate financial impact of these changes.

31 high priority 31 total filings
· daily

US Corporate Board Director Changes SEC Filings — July 13, 2026

The July 13, 2026, board room changes stream reveals a high volume of leadership transitions across 31 filings, with a notable cluster of CEO and CFO departures in the technology and life sciences sectors. Key themes include orderly succession planning at companies like Brown-Forman and Klaviyo, contrasted with a contentious director resignation at Fermi Inc. over governance concerns. While most changes are routine, the data highlights a significant number of CFO and C-suite exits, including at CoStar Group, Shutterstock, and MBX Biosciences, suggesting a period of strategic realignment. Insider trading activity is sparse in these filings, but forward-looking statements from Brown-Forman (reiterated FY2027 outlook) and Klaviyo (planned CFO transition with advisory period) provide stability signals. The most critical development is the Fermi Inc. director resignation, which raises governance red flags and warrants close monitoring.

31 high priority 31 total filings
· daily

USA Insider Trading Pulse — July 13, 2026

Today's insider trading filings reveal a pronounced divergence between high-conviction insider buying and large-scale disposals, primarily through option exercises and share-for-tax withholdings. The most notable bullish signal is a $2.18M open-market purchase by Dreamland Ltd's CEO, signaling strong management confidence. Conversely, a massive $401M sale by a SharkNinja director and a $294M sale by United Microelectronics Corp's CFO raise significant caution flags. A cluster of 'disposed to issuer' transactions at Esperion Therapeutics, totaling over 4 million shares from top executives, suggests a major corporate restructuring or buyout event. Sector-wise, insider selling is concentrated among tech and growth names, while value-oriented industrials and real estate see insider accumulation. The data also highlights a wave of restricted stock unit vestings and tax-withholding sales, which are less directional but still increase supply. Overall, the pattern points to a cautious but opportunistic market, with select pockets of deep insider conviction.

50 high priority 50 total filings